About
SynVaccine has developed a CAD/CAM platform for designing and fabricating designer viruses for biotechnology. The company utilizes a multidisciplinary approach combining technologies, such as synthetic biology, virology, bio-informatics, engineering, and robotics, to make viruses that can be used to develop new vaccines. SynVaccine's technology enables the design and fabrication of viral genomes using a safety-focused design approach. The resulting viruses have the potential to overcome the limitations of those found in nature or developed through traditional technologies. SynVaccine was founded as part of Rad BioMed, an Israel-based evergreen family fund that invests in early-stage biomedical start-ups, and on the basis of commercialized research from Tel Aviv University and Weizmann Institute of Science led by Professor Tamir Tuller.
Funding history · 1 round · $1.8M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is SynVaccine's core technology?
- SynVaccine has developed a CAD/CAM platform for designing and fabricating designer viruses for biotechnology, combining synthetic biology, virology, bio-informatics, engineering, and robotics.
- When was SynVaccine founded and by whom?
- SynVaccine was founded in July 2013 by Tamir Tuller and Tuval Ben Yehezkel. It was established as part of Rad BioMed and based on research from Tel Aviv University and Weizmann Institute of Science.
- What was SynVaccine's last funding round?
- SynVaccine completed a Seed funding round in November 2017, raising $1.7 million. Investors included A2Z Venture Partners and Pix Vine Capital. For a full financing history, please refer to startupim.
- Has SynVaccine received any grants?
- Yes, SynVaccine received a grant of $56,000 from the IIA in June 2017.
- What is the current employee count for SynVaccine?
- SynVaccine currently has 6 employees.
- What is the primary sector SynVaccine operates in?
- SynVaccine's primary sector is Health Tech & Life Sciences, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
- What is the name of SynVaccine's product?
- SynVaccine's product is named SynRAD.
- Where is SynVaccine's headquarters located?
- SynVaccine's headquarters is located at HaBarzel Street 27, Tel Aviv-Yafo, Israel.